Tanner Pharma
Tanner Pharma Group, commonly referred to as Tanner Pharma, is a leading provider of global access solutions for patients in need of critical medications. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, focusing on the pharmaceutical industry. Founded in 2008, Tanner Pharma has achieved significant milestones, including the development of innovative programmes that facilitate access to life-saving therapies. The company specialises in providing comprehensive services such as patient access programmes, clinical trial support, and supply chain management. What sets Tanner Pharma apart is its commitment to ensuring that patients receive the medications they require, regardless of geographical or financial barriers. With a strong market position and a reputation for excellence, Tanner Pharma continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Tanner Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tanner Pharma's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tanner Pharma's reported carbon emissions
Tanner Pharma, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or initiatives related to their carbon footprint. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical sector are increasingly committing to sustainability and climate action. This often includes setting science-based targets for emissions reductions, engaging in carbon offset programmes, and implementing energy efficiency measures. While Tanner Pharma has not disclosed specific commitments or initiatives, the industry trend indicates a growing focus on reducing Scope 1, 2, and 3 emissions to mitigate climate impact. As the company progresses, it may adopt similar strategies to enhance its environmental responsibility and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tanner Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
